BioWorld MedTech

Sep. 17, 2010

New ventures: IntriMed aims to address device industry challenges

A contract manufacturing company that believes "good enough" isn't has been created to help medical device makers address the increasing challenges in the industry. (Medical Device Daily) Read More

Analysts have positive outlook for HeartWare's ADVANCE trial

Report from Europe: Medtronic DBS system gets CE mark for epilepsy indication

Washington roundup: FDA includes Maquet's tardy reply to 483 in warning letter

Financings roundup: Cardinal sells last shares of CareFusion for $705.9M

MDD's food for med-tech thought

Agreements/contracts: MDI, Wells Fargo offer new data analysis series

Med-Tech Notes

HIT roundup: Element115 extends FatWire capabilities via acquisition

People in the News

Patent watch: Amedica granted two new patents for TDR technology

Product Briefs

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 14, 2025.

European VCs optimistic for med-tech exit opportunities in 2025

BioWorld MedTech

To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Feb. 14, 2025

European VCs bullish on med-tech investments in 2025

BioWorld MedTech

European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...

3D illustration of acute myeloid leukemia cells

Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML

BioWorld

Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...